Filing Flows › Arcturus Therapeutics Holdings (ARCT) › How it makes money
How Arcturus Therapeutics Holdings (ARCT) makes money
Arcturus Therapeutics Holdings (ARCT) made $18.3M of revenue in the third quarter 2026 (Q3 2026), +7% from a year earlier. Collaboration Revenue brought in $16.9M (92%); Grant brought in $1.4M (8%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Collaboration Revenue | $16.9M | 92.1% | 19× | +19% |
| Grant | $1.4M | 7.9% | -30% | -52% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $18.3M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $18.3M | +7% |
| Q2 2026 | $3.0M | -90% |
| Q1 2026 | $2.1M | -93% |
| Q4 2025 | $7.2M | -68% |
| Q3 2025 | $17.2M | -59% |
| Q2 2025 | $28.3M | -43% |
| Q1 2025 | $29.4M | -23% |
From Arcturus Therapeutics Holdings' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Arcturus Therapeutics Holdings make money?
Arcturus Therapeutics Holdings (ARCT) made $18.3M of revenue in the third quarter 2026 (Q3 2026), +7% from a year earlier. Collaboration Revenue brought in $16.9M (92%); Grant brought in $1.4M (8%).
What is Arcturus Therapeutics Holdings' biggest business?
Collaboration Revenue: $16.9M in the third quarter 2026, 92% of revenue, +19% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.